SCHEMBL7708456

SCHEMBL7708456

CN1CCN(c2nc(N)ncc2Cc2ccc(O)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 7/20 0.55
▸ HRH3 Q9Y5N1 2/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ HTR6 P50406 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714282 0.89 HRH4 (0.56) HRH4HRH3KCNH2HTR6
SCHEMBL7708547 0.88 HTR6 (0.56) HRH4HRH3KCNH2HTR6
SCHEMBL7712449 0.88 HTR6 (0.56) HRH4HRH3KCNH2HTR6
SCHEMBL7714603 0.87 HRH4 (0.57) HRH4HRH3KCNH2HTR6
SCHEMBL7716594 0.85 HTR6 (0.58) HRH4HTR6
SCHEMBL7713555 0.85 HRH4 (0.52) HRH4HRH3KCNH2HTR6
SCHEMBL7714119 0.82 HRH4 (0.53) HRH4HTR6
SCHEMBL7714720 0.81 HRH4 (0.52) HRH4HRH3KCNH2HTR6
SCHEMBL7712480 0.79 KMT2A (0.45) HRH4HTR6
SCHEMBL8124120 0.77 HTR6 (0.45) HRH4HRH3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 — — EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 — — WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 — — US disclosed
Send feedback